Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China.

Authors:
Wang Y; Lu C; Li H; Qi W; Ruan L and 23 more

Journal:
J Ethnopharmacol

Publication Year: 2021

DOI:
10.1016/j.jep.2021.113888

PMCID:
PMC7847283

PMID:
33529638

Journal Information

Full Title: J Ethnopharmacol

Abbreviation: J Ethnopharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Social Sciences

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that they have no conflict of interest."

Evidence found in paper:

"Funding This study was funded by the National Key Research and Development Plan for the Emergency Management of Novel Coronavirus Pneumonia (No. 2020YFC0841500)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025